Ej. Fuchs et al., P53-DEPENDENT DNA DAMAGE-INDUCED APOPTOSIS REQUIRES FAS APO-1-INDEPENDENT ACTIVATION OF CPP32-BETA/, Cancer research, 57(13), 1997, pp. 2550-2554
In many cell types, the p53 tumor suppressor protein is required for t
he induction of apoptosis by DNA-damaging chemotherapy or radiation. T
herefore, identification of the molecular determinants of p53-dependen
t cell death may aid in the design of effective therapies of p53-defic
ient cancers. We investigated whether p53-dependent apoptosis requires
activation of CPP32 beta (caspase 3), a cysteine protease that has be
en found to mediate apoptosis in response to ligation of the Fas molec
ule or to granzyme B, a component of CTL lytic granules. Irradiation-i
nduced apoptosis was associated with p53-dependent activation of CPP32
beta-related proteolysis, and normal thymocytes were protected from i
rradiation by Acetyl-Asp-Glu-Val-Asp-CHO (Ac-DEVD-CHO), a specific inh
ibitor of CPP32 beta. We next examined whether the Fas system is requi
red for p53-dependent apoptosis and whether stimuli that induce activa
tion of CPP32 beta induce apoptosis in p53-deficient cells. Thymocytes
or activated T cells from Fas-deficient mice were resistant to apopto
sis induced by ligation of Fas or CD3, respectively, but remained norm
ally susceptible to irradiation. Thymocytes from p53-deficient mice, a
lthough resistant to DNA damage, remained sensitive to CPP32 beta-medi
ated apoptosis induced by ligation of Fas or CD3, or by exposure to cy
totoxic T cells. These results demonstrate that DNA damage-induced apo
ptosis of T cells requires p53-mediated activation of CPP32 beta by a
mechanism independent of Fas/FasL interactions and suggest that immuno
logical or molecular methods of activating CPP32 beta may be effective
at inducing apoptosis in p53-deficient cancers that are resistant to
conventional chemotherapy or irradiation.